Literature DB >> 30448600

Prevalence and Severity of Nonalcoholic Fatty Liver Disease Among Caregivers of Patients With Nonalcoholic Fatty Liver Disease Cirrhosis.

Mohammad Shadab Siddiqui1, Salvatore Carbone2, Robert Vincent1, Samarth Patel1, Carolyn Driscoll1, Francesco S Celi3, Hayley Billingsley2, Brando Rotelli2, Binu John4, Nicola Potere2, Michele Viscusi2, Veronica Adiletta2, Arun J Sanyal1, Velimir A Luketic1, Trevor Reichman5, Chandra S Bhati6.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting nearly 1 in 3 Americans.1 Nonalcoholic steatohepatitis (NASH), the clinically aggressive variant of NAFLD, has a propensity of fibrosis progression and increased risk of cirrhosis and hepatocellular carcinoma. NASH-related cirrhosis is now the most rapidly growing indication for liver transplantation (LT).2 Disease recurrence and progression to advanced fibrosis after LT are high3; however, the key contributors of these are unknown. We hypothesized that patients with NASH cirrhosis reside in a microenvironment conducive to not only development of NASH but also fibrosis progression, which likely persist after LT and contribute to disease recurrence. The hypothesis was tested by performing vibration-controlled transient elastography (VCTE) in primary caregivers and cohabitants of patients with decompensated cirrhosis awaiting LT.
Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30448600      PMCID: PMC7018437          DOI: 10.1016/j.cgh.2018.11.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  8 in total

1.  Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study.

Authors:  Raymond Kwok; Kai Chow Choi; Grace Lai-Hung Wong; Yuying Zhang; Henry Lik-Yuen Chan; Andrea On-Yan Luk; Sally She-Ting Shu; Anthony Wing-Hung Chan; Ming-Wai Yeung; Juliana Chung-Ngor Chan; Alice Pik-Shan Kong; Vincent Wai-Sun Wong
Journal:  Gut       Date:  2015-04-14       Impact factor: 23.059

2.  Vibration-Controlled Transient Elastography to Assess Fibrosis and Steatosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Mohammad S Siddiqui; Raj Vuppalanchi; Mark L Van Natta; Erin Hallinan; Kris V Kowdley; Manal Abdelmalek; Brent A Neuschwander-Tetri; Rohit Loomba; Srinivasan Dasarathy; Danielle Brandman; Edward Doo; James A Tonascia; David E Kleiner; Naga Chalasani; Arun J Sanyal
Journal:  Clin Gastroenterol Hepatol       Date:  2018-04-26       Impact factor: 11.382

3.  Dietary patterns are associated with prevalence of fatty liver disease in adults.

Authors:  Q Jia; Y Xia; Q Zhang; H Wu; H Du; L Liu; C Wang; H Shi; X Guo; X Liu; C Li; S Sun; X Wang; H Zhao; K Song; G Huang; Y Wu; N Cui; K Niu
Journal:  Eur J Clin Nutr       Date:  2015-02-04       Impact factor: 4.016

4.  Long-term Outcomes in Patients Undergoing Liver Transplantation for Nonalcoholic Steatohepatitis-Related Cirrhosis.

Authors:  Chandra Bhati; Michael O Idowu; Arun J Sanyal; Maria Rivera; Carolyn Driscoll; Richard T Stravitz; Divyanshoo R Kohli; Scott Matherly; Puneet Puri; HoChong Gilles; Adrian Cotterell; Marlon Levy; Richard K Sterling; Velimir A Luketic; Hannah Lee; Amit Sharma; Mohammad Shadab Siddiqui
Journal:  Transplantation       Date:  2017-08       Impact factor: 4.939

5.  Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity.

Authors:  Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States.

Authors:  Robert J Wong; Maria Aguilar; Ramsey Cheung; Ryan B Perumpail; Stephen A Harrison; Zobair M Younossi; Aijaz Ahmed
Journal:  Gastroenterology       Date:  2014-11-25       Impact factor: 22.682

7.  Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease.

Authors:  Charlie C Park; Phirum Nguyen; Carolyn Hernandez; Ricki Bettencourt; Kimberly Ramirez; Lynda Fortney; Jonathan Hooker; Ethan Sy; Michael T Savides; Mosab H Alquiraish; Mark A Valasek; Emily Rizo; Lisa Richards; David Brenner; Claude B Sirlin; Rohit Loomba
Journal:  Gastroenterology       Date:  2016-10-27       Impact factor: 22.682

8.  The Western dietary pattern is prospectively associated with nonalcoholic fatty liver disease in adolescence.

Authors:  Wendy H Oddy; Carly E Herbison; Peter Jacoby; Gina L Ambrosini; Therese A O'Sullivan; Oyekoya T Ayonrinde; John K Olynyk; Lucinda J Black; Lawrence J Beilin; Trevor A Mori; Beth P Hands; Leon A Adams
Journal:  Am J Gastroenterol       Date:  2013-04-02       Impact factor: 10.864

  8 in total
  6 in total

Review 1.  Current management of non-alcoholic steatohepatitis.

Authors:  Mark D Muthiah; Arun J Sanyal
Journal:  Liver Int       Date:  2020-02       Impact factor: 5.828

Review 2.  Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant.

Authors:  Anchalia Chandrakumaran; Mohammad Shadab Siddiqui
Journal:  Gastroenterol Clin North Am       Date:  2020-03       Impact factor: 3.806

Review 3.  Treatments for obesity in the context of nonalcoholic steatohepatitis and mental health.

Authors:  Aadi Sharma; Somaya Albhaisi; Arun J Sanyal
Journal:  Clin Liver Dis (Hoboken)       Date:  2022-07-16

Review 4.  Comprehensive Review and Updates on Holistic Approach Towards Non-Alcoholic Fatty Liver Disease Management with Cardiovascular Disease.

Authors:  Nicholas W S Chew; Cheng Han Ng; Mark Dhinesh Muthiah; Arun J Sanyal
Journal:  Curr Atheroscler Rep       Date:  2022-05-04       Impact factor: 5.967

5.  Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease.

Authors:  Qi Shao; Yiping Wu; Jing Ji; Tian Xu; Qiaoyu Yu; Chongyang Ma; Xuejing Liao; Fafeng Cheng; Xueqian Wang
Journal:  Front Psychiatry       Date:  2021-12-13       Impact factor: 4.157

6.  Screening of Family Members of Nonalcoholic Fatty Liver Disease Patients can Detect Undiagnosed Nonalcoholic Fatty Liver Disease Among Them: Is There a Genetic Link?

Authors:  Shubham Jain; Ravi Thanage; Falguni Panchal; Pravin M Rathi; Renuka Munshi; Suhas S Udgirkar; Qais Q Contractor; Sanjay J Chandnani; Nair P Sujit; Partha Debnath; Anupam Singh
Journal:  J Clin Exp Hepatol       Date:  2020-10-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.